<DOC>
	<DOC>NCT01257633</DOC>
	<brief_summary>The main objective of this study is to determine the rate of healthy surgical margins after tumor resection in transoral robot-assisted surgery for glottic and/or supraglottic early stage (T1-T2) laryngeal cancer.</brief_summary>
	<brief_title>Surgical Treatment of Early Stage Glotto-supraglottic Laryngeal Cancer Via Transoral Resection With Robotic Assistance</brief_title>
	<detailed_description />
	<mesh_term>Laryngeal Neoplasms</mesh_term>
	<criteria>The subject has signed consent The subject must be a member or beneficiary of a health insurance plan The patient is available for 12 months of followup The subject has a cancer of the larynx: classified T1 or T2 in the TNM glottic localization and / or supraglottic regardless of node status with or without a history of head and neck cancer The subject does not have distant metastasis (M0) A decision for endoscopic robotassisted surgery is retained in multidisciplinary meeting</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>da Vinci surgical robot</keyword>
	<keyword>laryngeal cancer</keyword>
</DOC>